WASHINGTON, DC—In patients with right ventricular outflow tract (RVOT) conduit dysfunction, transcatheter pulmonary valve (TPV) replacement demonstrates high procedural success, excellent short-term ...
Prolonged academic work frequently leads to severe mental exhaustion and scattered attention. Establishing a controlled auditory environment serves as a highly effective method to block out external ...
Palatin Technologies, Inc. PTN announced that it has initiated the pivotal phase III MELODY-1 study evaluating its melanocortin agonist, PL9643, for the treatment of patients with dry eye disease ...
CRANBURY, N.J., Dec. 28, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that ...
Palatin Technologies, Inc., a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system, ...
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer. This is an ASCO Meeting Abstract ...
A new study that reviewed Billboard hits from the past 73 years found a steady simplification of rhythm and pitch. Credit... Supported by By Alexander Nazaryan “Well, we’re all in the mood for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results